Leber hereditary optic neuropathy: current perspectives.

Area of Science:

• Genetics
• Neuroscience
• Ophthalmology

Background:

• Leber hereditary optic neuropathy (LHON) is a common inherited optic neuropathy causing bilateral central vision loss.
• It stems from point mutations in mitochondrial DNA, leading to mitochondrial dysfunction and retinal ganglion cell loss.
• LHON exhibits variable clinical phenotypes influenced by genetic and environmental factors, with males being more severely affected.

Purpose of the Study:

• To summarize the current understanding of Leber hereditary optic neuropathy (LHON).
• To highlight the pathophysiology, clinical presentation, and current management strategies.
• To discuss emerging therapeutic interventions for LHON.

Main Methods:

• Review of existing literature on Leber hereditary optic neuropathy.
• Analysis of genetic and etiological factors contributing to the disease.
• Evaluation of current and investigational treatment approaches.

Main Results:

• LHON primarily affects retinal ganglion cells due to impaired ATP production and oxidative stress.
• While most patients experience permanent vision loss, some show spontaneous partial recovery.
• No definitive curative treatments exist; management is supportive, focusing on low vision services and risk factor mitigation.

Conclusions:

• LHON is a significant cause of inherited vision loss with complex genetic and environmental influences.
• Current management is supportive, but novel therapies targeting mitochondrial function and neuroprotection are under investigation.
• Emerging treatments like idebenone, gene therapy, and stem cells offer potential for restoring vision in LHON patients.